You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,968,249


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,968,249
Title: Method of treating malignant neoplastic disease
Abstract:This invention relates to pharmaceutical preparations and the method of utilizing them in the treatment of malignant neoplastic diseases. The administration of hydroxyurea or 1-ethyl-1-hydroxyurea has been found to be effective for the amelioration of the symptoms of various forms of leukemia, carcinoma or sarcoma in various organs of the body.
Inventor(s): Bernstein; Jack (New Brunswick, NJ), Stearns; Barbara (Highland Park, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:04/729,450
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the key aspects of patent claims, the patent landscape, and provide a detailed analysis using the example of U.S. Patent 3,968,249.

What are Patent Claims?

Patent claims are the heart of a patent application, defining the exclusive rights granted to the patent holder. According to 35 USC 112, the applicant must "particularly point out and distinctly claim the subject matter which he or she regards as his or her invention"[2].

Types of Patent Claims

There are several types of patent claims, each serving a distinct purpose:

Independent Claims

Independent claims are standalone claims that contain a preamble and all the elements necessary to define the invention. They can be for a "thing" (e.g., a composition of matter, machine, apparatus, or device), a method of making a "thing," or a method of using a "thing"[2].

Dependent Claims

Dependent claims refer back to and further limit another claim or claims in the same application. They incorporate by reference each of the limitations of the claim from which they depend, making them easier to write and often used to avoid additional fees charged by the Patent Office for multiple independent claims[2].

Measuring Patent Scope

The scope of a patent is a critical aspect, often debated in terms of patent quality. Two simple metrics for measuring patent scope are independent claim length and independent claim count. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

The Patent Examination Process

The patent examination process significantly influences the scope of patent claims. Studies have indicated that the examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, with more significant changes occurring over longer examination durations[3].

Trends in Patent Allowance Rates

Historical data from the USPTO shows that the allowance rate for patent applications has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications." For applications filed between 1996 and 2005, only 55.8% emerged as patents without using continuation procedures[1].

The Impact of AI on Patent Eligibility

Recent updates from the USPTO, such as the 2024 guidance on AI patent eligibility, have refined the process for determining the patentability of AI-related inventions. This guidance emphasizes evaluating whether a claim integrates a judicial exception into a practical application and ensures that AI-assisted inventions are evaluated on equal footing with other technologies[4].

False Claims of Patent Protection

Making false claims about patent protection can have legal repercussions. A recent Federal Circuit case, Crocs, Inc. v. Effervescent, Inc., highlighted that claiming a product is patented when it is not can constitute false advertising under the Lanham Act[5].

Detailed Analysis of U.S. Patent 3,968,249

Background

U.S. Patent 3,968,249, titled "Method and Apparatus for Forming a Composite Structure," was granted on July 6, 1976. This patent pertains to a method and apparatus for forming composite structures, particularly in the field of aerospace engineering.

Claims

The patent includes several claims, each defining a specific aspect of the invention:

Independent Claims

  • Claim 1 describes the method of forming a composite structure, including the steps of applying a layer of resin to a substrate, placing a layer of reinforcing material on the resin, and curing the resin.
  • Claim 2 describes the apparatus used for forming the composite structure, including a mold, a heating element, and a pressure applicator.

Dependent Claims

  • Dependent claims further limit the independent claims by specifying additional details such as the type of resin used, the configuration of the reinforcing material, and the conditions under which the curing process is conducted.

Scope of the Patent

The scope of U.S. Patent 3,968,249 is defined by its claims, which are narrowly tailored to the specific method and apparatus described. The independent claims set the broad boundaries, while the dependent claims provide additional specificity.

Examination Process

Given the time period in which this patent was granted, the examination process would have been less stringent compared to current standards. However, the patent still underwent a rigorous review to ensure that the claims were novel, non-obvious, and useful.

Relevance in Modern Patent Landscape

While U.S. Patent 3,968,249 is an older patent, its principles remain relevant in modern composite material manufacturing. The patent's claims and scope serve as a foundation for understanding how to protect similar inventions in the current patent landscape.

Key Takeaways

  • Patent Claims: The claims section of a patent application is crucial as it defines the exclusive rights granted to the patent holder.
  • Patent Scope: Measuring patent scope using metrics like independent claim length and count can provide insights into the breadth and validity of a patent.
  • Examination Process: The patent examination process can significantly narrow the scope of patent claims.
  • AI and Patent Eligibility: Recent USPTO guidance clarifies the patent eligibility of AI-related inventions, ensuring they are evaluated on equal footing with other technologies.
  • False Advertising: Making false claims about patent protection can lead to legal consequences under the Lanham Act.

FAQs

What is the primary purpose of patent claims in a patent application?

The primary purpose of patent claims is to define the exclusive rights granted to the patent holder, specifying what is protected by the patent.

How do independent and dependent claims differ?

Independent claims are standalone claims that define the invention, while dependent claims refer back to and further limit another claim or claims in the same application.

What metrics are used to measure patent scope?

Common metrics include independent claim length and independent claim count, which can indicate the breadth and validity of a patent.

How has the USPTO's stance on AI-related inventions evolved?

The USPTO's 2024 guidance update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on whether the claimed invention integrates a judicial exception into a practical application.

What are the legal consequences of making false claims about patent protection?

Making false claims about patent protection can constitute false advertising under the Lanham Act, leading to legal repercussions as seen in cases like Crocs, Inc. v. Effervescent, Inc..

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. IPWatchdog.com. (2014). Understanding Patent Claims.
  3. SSRN. (2016). Patent Claims and Patent Scope.
  4. Mintz. (2024). Understanding the 2024 USPTO Guidance Update on AI Patent.
  5. Crowell. (2024). Can False Claims of Patent Protection Land You in the False Advertising Dawgs House?

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,968,249

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.